**Question:** A 75-year-old frail elderly man underwent TURP. The biopsy revealed adenocarcinoma. What is the next line of management -

A. Surgery
B. Chemotherapy
C. Radiotherapy
D. Hormone therapy

**Core Concept:**
The pharmacological management of prostate cancer depends on the stage, grade, and tumor biology of the cancer. In this context, we need to consider the patient's age, overall health, and the extent of cancer spread.

**Why the Correct Answer is Right:**
For this patient, hormone therapy (D) is the most appropriate management option. Frail elderly patients with prostate cancer often have hormone-sensitive tumors, meaning that the cancer cells respond to androgen deprivation. In this situation, the patient has undergone transurethral resection of the prostate (TURP), which may have caused transient hormonal changes.

**Why Each Wrong Option is Incorrect:**
A. Surgery (TURP) has been done, and further surgery is not recommended without discussing with a urologist.
B. Chemotherapy is usually reserved for patients with advanced or systemic disease, not suitable for a frail elderly patient with localized prostate cancer.
C. Radiotherapy is also not ideal for this patient due to the risk of complications in elderly patients after radiation therapy.

**Clinical Pearl:**
In frail elderly patients with localized prostate cancer, hormone therapy is often the best choice, considering the patient's age, comorbidities, and the hormonal response of the tumor. This approach minimizes surgical and radiation-related complications and allows for personalized management. However, a thorough discussion with a urologist is crucial before initiating any treatment plan.